In 2025, the FDA approved Wegovy HD a higher-dose semaglutide formulation for metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH
Emerge Weight Loss Review A community-focused GLP1 provider centered on compounded tirzepatide
Daily supplement timing framework Morning with breakfast: Multivitamin, B-complex, vitamin D3 with K2 (with food containing fat), first protein serving, omega-3 (with food) Between meals: Protein shake as needed, electrolytes With lunch or dinner: Calcium citrate (first dose), iron (if prescribed, separate from calcium by 2 hours), zinc (with food) Evening: Magnesium glycinate (30 to 60 minutes before bed), calcium citrate (second dose if splitting), casein protein (optional bedtime shake), probiotics (bedtime on empty stomach) During dose escalation weeks The first one to two weeks after each dose increase typically bring the worst GI side effects
Tirzepatide typically produces stronger appetite suppression than semaglutide at equivalent therapeutic doses
Losing weight can be challenging
It also instructs the pancreas to secrete insulin, which decreases blood sugar levels
.png)
